Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development

키워드

참고문헌 (90)

1. Kim YC, "Microneedles for drug and vaccine delivery", Adv Drug Deliv Rev, 64, pp.1547~1568 (2012)
2. Rejinold NS, "Biomedical applications of microneedles in therapeutics : recent advancements and implications in drug delivery", Expert Opin Drug Deliv, 13, pp.109~131 (2016)
3. Waghule T, "Microneedles : a smart approach and increasing potential for transdermal drug delivery system", Biomed Pharmacother, 109, pp.1249~1258 (2019)
4. Prausnitz MR, "Microneedles for transdermal drug delivery", Adv Drug Deliv Rev, 56, pp.581~587 (2004)
5. Ita K, "Transdermal delivery of drugs with microneedles—potential and challenges", Pharmaceutics, 7, pp.90~105 (2015)
6. Ono A, "Development of novel faster-dissolving microneedle patches for transcutaneous vaccine delivery", Pharmaceutics, 9, pp.27~ (2017)
7. Yang J, "Recent advances of microneedles for biomedical applications : drug delivery and beyond", Acta Pharm Sin B, 9, pp.469~483 (2019)
8. Menon I, "Microneedles: a new generation vaccine delivery system", Micromachines (Basel), 12, pp.435~ (2021)
9. Kim JD, "Droplet-born air blowing : novel dissolving microneedle fabrication", J Control Release, 170, pp.430~436 (2013)
10. Frew AJ, "Allergen immunotherapy", J Allergy Clin Immunol, 125(2 Suppl 2), pp.S306~S313 (2010)
11. Scheurer S, "Epicutaneous immunotherapy", Allergol Immunopathol (Madr), 45(Suppl 1), pp.25~29 (2017)
12. Liu G, "The role of regulatory T cells in epicutaneous immunotherapy for food allergy", Front Immunol, 12, pp.660974~ (2021)
13. Wang Y, "Innovative systems to deliver allergen powder for epicutaneous immunotherapy", Front Immunol, 12, pp.647954~ (2021)
14. Mondoulet L, "Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts", Int Arch Allergy Immunol, 154, pp.299~309 (2011)
15. Dupont C, "Cow’s milk epicutaneous immunotherapy in children : a pilot trial of safety, acceptability, and impact on allergic reactivity", J Allergy Clin Immunol, 125, pp.1165~1167 (2010)
16. Dioszeghy V, "Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice", J Immunol, 186, pp.5629~5637 (2011)
17. Mondoulet L, "Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model", J Allergy Clin Immunol, 135, pp.1546~1557.e4 (2015)
18. Fleischer DM, "Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy : the PEPITES randomized clinical trial", JAMA, 321, pp.946~955 (2019)
19. Mondoulet L, "Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy(EPIT)in mice", Clin Transl Allergy, 2, pp.22~ (2012)
20. Senti G, "Epicutaneous allergen administration : is this the future of allergen-specific immunotherapy?", Allergy, 66, pp.798~809 (2011)
21. Wang J, "Safety and efficacy of epicutaneous immunotherapy for food allergy", Pediatr Allergy Immunol, 29, pp.341~349 (2018)
22. Bariya SH, "Microneedles : an emerging transdermal drug delivery system", J Pharm Pharmacol, 64, pp.11~29 (2012)
23. Yu Y, "Delivery of allergen powder for safe and effective epicutaneous immunotherapy", J Allergy Clin Immunol, 145, pp.597~609 (2020)
24. 김지태, "Comparison of Allergenic Properties among Commercially Available House Dust Mite Allergen Extracts in Korea", Yonsei Medical Journal, 62(1), pp.86~90 (2021), 연세대학교의과대학[DOI]
25. Kim JH, "Successful transdermal allergen delivery and allergen-specific immunotherapy using biodegradable microneedle patches", Biomaterials, 150, pp.38~48 (2018)
26. Park KH, "Efficacy of transdermal immunotherapy with biodegradable microneedle patches in a murine asthma model", Clin Exp Allergy, 50, pp.1084~1092 (2020)
27. Yang D, "Microneedle-mediated transdermal drug delivery for treating diverse skin diseases", Acta Biomater, 121, pp.119~133 (2021)
28. Yu YQ, "Enhancing permeation of drug molecules across the skin via delivery in nanocarriers : novel strategies for effective transdermal applications", Front Bioeng Biotechnol, 9, pp.646554~ (2021)
29. Hong JY, "Efficacy and safety of a novel, soluble microneedle patch for the improvement of facial wrinkle", J Cosmet Dermatol, 17, pp.235~241 (2018)
30. Avcil M, "Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches : a monocentric clinical study", J Cosmet Dermatol, 19, pp.328~337 (2020)
31. 박지훈, "생분해성 마이크로니들 패치(Biodegradable Microneedle Patch)를 이용한 눈가 주름의 개선에 관한 연구", 대한피부과학회지, 52(9), pp.597~607 (2014), 대한피부과학회
32. Brown TJ, "Absorption of hyaluronan applied to the surface of intact skin", J Invest Dermatol, 113, pp.740~746 (1999)
33. Frei B, "Reactive oxygen species and antioxidant vitamins : mechanisms of action", Am J Med, 97(Supplement 1), pp.S5~S13 (1994)
34. Lee C, "Evaluation of the anti-wrinkle effect of an ascorbic acid-loaded dissolving microneedle patch via a double-blind, placebo-controlled clinical study", Int J Cosmet Sci, 38, pp.375~381 (2016)
35. Costin GE, "Human skin pigmentation : melanocytes modulate skin color in response to stress", FASEB J, 21, pp.976~994 (2007)
36. Son KH, "The evaluation of depigmenting efficacy in the skin for the development of new whitening agents in Korea", Int J Cosmet Sci, 35, pp.9~18 (2013)
37. Avcil M, "Clinical efficacy of dissolvable microneedles armed with anti-melanogenic compounds to counter hyperpigmentation", J Cosmet Dermatol, 20, pp.605~614 (2021)
38. Kim TK, "Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro", Mol Cell Endocrinol, 404, pp.1~8 (2015)
39. Monavarian M, "Regenerative scar-free skin wound healing", Tissue Eng Part B Rev, 25, pp.294~311 (2019)
40. Singh A, "Microneedling : advances and widening horizons", Indian Dermatol Online J, 7, pp.244~254 (2016)
41. Xie Y, "Enhanced in vitro efficacy for inhibiting hypertrophic scar by bleomycin-loaded dissolving hyaluronic acid microneedles", J Mater Chem B, 7, pp.6604~6611 (2019)
42. Fabbrocini G, "Percutaneous collagen induction : an effective and safe treatment for post-acne scarring in different skin phototypes", J Dermatolog Treat, 25, pp.147~152 (2014)
43. Almohanna HM, "Safety concerns when using novel medications to treat alopecia", Expert Opin Drug Saf, 17, pp.1115~1128 (2018)
44. 김윤섭, "Repeated Microneedle Stimulation Induces Enhanced Hair Growth in a Murine Model", Annals of Dermatology, 28(5), pp.586~592 (2016), 대한피부과학회
45. Bao L, "Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male androgenetic alopecia", J Cosmet Laser Ther, 22, pp.1~7 (2020)
46. Yang G, "A therapeutic microneedle patch made from hair-derived keratin for promoting hair regrowth", ACS Nano, 13, pp.4354~4360 (2019)
47. Jensen P, "Systemic combination treatment for psoriasis : a review", Acta Derm Venereol, 90, pp.341~349 (2010)
48. Sabri AH, "Expanding the applications of microneedles in dermatology", Eur J Pharm Biopharm, 140, pp.121~140 (2019)
49. Du H, "Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis", ACS Appl Mater Interfaces, 11, pp.43588~43598 (2019)
50. Jeong HR, "Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles", Eur J Pharm Biopharm, 127, pp.237~243 (2018)
51. Korkmaz E, "Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays", Acta Biomater, 24, pp.96~105 (2015)
52. Lee MR, "Prurigo nodularis : a review", Australas J Dermatol, 46, pp.211~218 (2005)
53. Kowalski EH, "Treatment-resistant prurigo nodularis : challenges and solutions", Clin Cosmet Investig Dermatol, 12, pp.163~172 (2019)
54. Shin JU, "The use of biodegradable microneedle patches to increase penetration of topical steroid for prurigo nodularis", Eur J Dermatol, 28, pp.71~77 (2018)
55. Lee SJ, "Use of fractionated microneedle radiofrequency for the treatment of inflammatory acne vulgaris in 18 Korean patients", Dermatol Surg, 38, pp.400~405 (2012)
56. Zhang T, "Active pharmaceutical ingredient poly(ionic liquid)-based microneedles for the treatment of skin acne infection", Acta Biomater, 115, pp.136~147 (2020)
57. Mellman I, "Cancer immunotherapy comes of age", Nature, 480, pp.480~489 (2011)
58. Teunissen MB, "Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design", Curr Top Microbiol Immunol, 351, pp.25~76 (2012)
59. Niu L, "Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response", J Control Release, 294, pp.268~278 (2019)
60. Lee SJ, "Enhanced anti-tumor immunotherapy by dissolving microneedle patch loaded ovalbumin", PLoS One, 14, pp.e0220382~ (2019)
61. Wang C, "Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody", Nano Lett, 16, pp.2334~2340 (2016)
62. Eigentler TK, "Diagnosis, monitoring and management of immunerelated adverse drug reactions of anti-PD-1 antibody therapy", Cancer Treat Rev, 45, pp.7~18 (2016)
63. Singh V, "Recent advances in microneedles-based drug delivery device in the diagnosis and treatment of cancer", J Control Release, 338, pp.394~409 (2021)
64. Yan G, "Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery", Int J Pharm, 391, pp.7~12 (2010)
65. Pamornpathomkul B, "Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery", Eur J Pharm Sci, 121, pp.200~209 (2018)
66. 윤동원, "Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005–2017", Yonsei Medical Journal, 61(7), pp.623~630 (2020), 연세대학교의과대학[DOI]
67. Weniger BG, "Cutaneous vaccination : antigen delivery into or onto the skin", Vaccine, 31, pp.3389~3391 (2013)
68. Jacoby E, "Opportunities and challenges in delivering influenza vaccine by microneedle patch", Vaccine, 33, pp.4699~4704 (2015)
69. Koutsonanos DG, "Transdermal influenza immunization with vaccine-coated microneedle arrays", PLoS One, 4, pp.e4773~ (2009)
70. Kim YC, "Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles", Procedia Vaccinol, 2, pp.15~19 (2010)
71. Koutsonanos DG, "Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and longlived protection", Sci Rep, 2, pp.357~ (2012)
72. Kang SM, "Microneedle and mucosal delivery of influenza vaccines", Expert Rev Vaccines, 11, pp.547~560 (2012)
73. Kim YC, "Improved influenza vaccination in the skin using vaccine coated microneedles", Vaccine, 27, pp.6932~6938 (2009)
74. Van Damme P, "Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults", Vaccine, 27, pp.454~459 (2009)
75. World Health Organization, "BCG vaccine. WHO position paper", Wkly Epidemiol Rec, 79, pp.27~38 (2004)
76. Flynn PM, "Influence of needle gauge in Mantoux skin testing", Chest, 106, pp.1463~1465 (1994)
77. Pasteur MC, "The effects of inadvertent intramuscular injection of BCG vaccine", Scand J Infect Dis, 33, pp.473~474 (2001)
78. Chen F, "BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination", J Control Release, 255, pp.36~44 (2017)
79. Quan FS, "Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin", PLoS One, 4, pp.e7152~ (2009)
80. Hiraishi Y, "Bacillus Calmette-Guérin vaccination using a microneedle patch", Vaccine, 29, pp.2626~2636 (2011)
81. Cristina Stasi, "Hepatitis B vaccination and immunotherapies: an update", Clinical and Experimental Vaccine Research, 9(1), pp.1~7 (2020), 대한백신학회
82. Perez Cuevas MB, "Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques", Bioeng Transl Med, 3, pp.186~196 (2018)
83. Choi YH, "Feasibility of hepatitis B vaccination by microneedle patch : cellular and humoral immunity studies in rhesus macaques", J Infect Dis, 220, pp.1926~1934 (2019)
84. Kim JS, "Microneedles with dual release pattern for improved immunological efficacy of hepatitis B vaccine", Int J Pharm, 591, pp.119928~ (2020)
85. Reñé R, "From high doses of oral rivastigmine to transdermal rivastigmine patches : user experience and satisfaction among caregivers of patients with mild to moderate Alzheimer disease", Neurologia, 29, pp.86~93 (2014)
86. Kearney MC, "Microneedle-mediated delivery of donepezil : potential for improved treatment options in Alzheimer’s disease", Eur J Pharm Biopharm, 103, pp.43~50 (2016)
87. Yan Q, "Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer's disease", Drug Deliv, 27, pp.1147~1155 (2020)
88. Dangol M, "Antiobesity effect of a novel caffeine-loaded dissolving microneedle patch in high-fat diet-induced obese C57BL", 6J mice, 2017, pp.265, 41~47
89. Than A, "Transdermal delivery of anti-obesity compounds to subcutaneous adipose tissue with polymeric microneedle patches", Small Methods, 1, pp.1700269~ (2017)
90. Zhang Y, "Locally induced adipose tissue browning by microneedle patch for obesity treatment", ACS Nano, 11, pp.9223~9230 (2017)

관련 논문AI추천